Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study.

Abstract:

BACKGROUND:Territorial differences in the access to innovative anticancer drugs have been reported from many countries. The objectives of this study were to evaluate access to innovative treatments for metastatic lung cancer in France, and to assess whether socioeconomic indicators were predictors of access at the level of the municipality of residence. METHODS:All incident cases of metastatic lung cancer hospitalised for a chemotherapy in public hospitals in 2011 were identified from the French National Hospital discharge database. Information on prescription of innovative drugs from an associated database (FICHCOMP) was crossed with the population density of the municipality and a social deprivation index based on national census data. RESULTS:Overall, 21,974 incident cases of metastatic lung cancer were identified, all of whom were followed for 2 years. Of the 11,486 analysable patients receiving chemotherapy in the public sector, 6959 were treated with a FICHCOMP drug at least once, principally pemetrexed. In multivariate analysis, prescription of FICHCOMP drugs was less frequent in patients ≥66 years compared to those ≤55 years (odds ratio: 0.49 [0.44-0.55]), in men compared to women (0.86 [0.79-0.94]) and in patients with renal insufficiency (0.55 [0.41-0.73]) and other comorbidities. Prescription rates were also associated with social deprivation, being lowest in the most deprived municipalities compared to the most privileged municipalities (odds ratio: 0.82 [0.72-0.92]). No association was observed between the population density of the municipality and access to innovative drugs. CONCLUSION:Although access to innovative medication in France seems to be relatively equitable, social deprivation is associated with poorer access. The reasons for this need to be investigated and addressed.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Scherpereel A,Durand-Zaleski I,Cotté FE,Fernandes J,Debieuvre D,Blein C,Gaudin AF,Tournier C,Vainchtock A,Chauvin P,Souquet PJ,Westeel V,Chouaïd C

doi

10.1186/s12885-018-4958-5

subject

Has Abstract

pub_date

2018-10-22 00:00:00

pages

1013

issue

1

issn

1471-2407

pii

10.1186/s12885-018-4958-5

journal_volume

18

pub_type

杂志文章
  • ZFP36 stabilizes RIP1 via degradation of XIAP and cIAP2 thereby promoting ripoptosome assembly.

    abstract:BACKGROUND:ZFP36 is an mRNA binding protein that exerts anti-tumor activity in glioblastoma by triggering cell death, associated to an increase in the stability of the kinase RIP1. METHODS:We used cell death assays, size exclusion chromatography, Co-Immunoprecipitation, shRNA lentivectors and glioma neural stem cells ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1388-5

    authors: Selmi T,Alecci C,dell' Aquila M,Montorsi L,Martello A,Guizzetti F,Volpi N,Parenti S,Ferrari S,Salomoni P,Grande A,Zanocco-Marani T

    更新日期:2015-05-06 00:00:00

  • Clinicopathological features of breast cancer patients with internal mammary and/or supraclavicular lymph node recurrence without distant metastasis.

    abstract:BACKGROUND:Internal mammary and/or supraclavicular (IM-SC) lymph node (LN) recurrence without distant metastasis (DM) in patients with breast cancer is rare, and there have been few reports on its clinical outcomes. METHODS:We enrolled 4237 patients with clinical stage I-IIIC breast cancer treated between January 2007...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07442-8

    authors: Inari H,Teruya N,Kishi M,Horii R,Akiyama F,Takahashi S,Ito Y,Ueno T,Iwase T,Ohno S

    更新日期:2020-09-29 00:00:00

  • Variation in the initial assessment and investigation for ovarian cancer in symptomatic women: a systematic review of international guidelines.

    abstract:BACKGROUND:Women with ovarian cancer can present with a variety of symptoms and signs, and an increasing range of tests are available for their investigation. A number of international guidelines provide advice for the initial assessment of possible ovarian cancer in symptomatic women. We systematically identified and ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6211-2

    authors: Funston G,Van Melle M,Baun ML,Jensen H,Helsper C,Emery J,Crosbie EJ,Thompson M,Hamilton W,Walter FM

    更新日期:2019-11-01 00:00:00

  • LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.

    abstract:BACKGROUND:The facts that LPA is present at high concentration in ovarian cancer patients' ascites and it may serve as a stimulator to cell migration, implicate the role of LPA in the ovarian cancer metastasis. Since LPA mediates various biological functions through its interaction with LPA receptors, we aim to investi...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2865-1

    authors: Yu X,Zhang Y,Chen H

    更新日期:2016-11-04 00:00:00

  • Comparing conVEntional RadioTherapy with stereotactIC body radiotherapy in patients with spinAL metastases: study protocol for an randomized controlled trial following the cohort multiple randomized controlled trial design.

    abstract:BACKGROUND:Standard radiotherapy is the treatment of first choice in patients with symptomatic spinal metastases, but is only moderately effective. Stereotactic body radiation therapy is increasingly used to treat spinal metastases, without randomized evidence of superiority over standard radiotherapy. The VERTICAL stu...

    journal_title:BMC cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s12885-016-2947-0

    authors: van der Velden JM,Verkooijen HM,Seravalli E,Hes J,Gerlich AS,Kasperts N,Eppinga WS,Verlaan JJ,van Vulpen M

    更新日期:2016-11-21 00:00:00

  • Impact of diabetes type II and chronic inflammation on pancreatic cancer.

    abstract:BACKGROUND:We explored if known risk factors for pancreatic cancer such as type II diabetes and chronic inflammation, influence the pathophysiology of an established primary tumor in the pancreas and if administration of metformin has an impact on tumor growth. METHODS:Pancreatic carcinomas were assessed in a syngenei...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1047-x

    authors: Zechner D,Radecke T,Amme J,Bürtin F,Albert AC,Partecke LI,Vollmar B

    更新日期:2015-02-13 00:00:00

  • Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer.

    abstract:BACKGROUND:Cyclo-oxygenase-2 (COX-2), the key enzyme in the conversion of arachidonic acid to prostaglandins, is involved in critical steps of tumor onset and progression, and is a strong predictor of chemotherapy resistance and poor outcome in advanced ovarian cancer. To our knowledge, no data has been reported until ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-6-182

    authors: Ferrandina G,Ranelletti FO,Martinelli E,Paglia A,Zannoni GF,Scambia G

    更新日期:2006-07-11 00:00:00

  • Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1/NF-κB/slug/E-cadherin pathway.

    abstract:BACKGROUND:Genistein has been known to inhibit proliferation and induce apoptosis in several kinds of cancer cells. While knowledge of genistein in regulating epithelial mesenchymal transition (EMT) of colon cancer cells is unknown. METHODS:To investigate the effects and mechanisms of genistein on EMT of colon cancer ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3829-9

    authors: Zhou P,Wang C,Hu Z,Chen W,Qi W,Li A

    更新日期:2017-12-04 00:00:00

  • Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.

    abstract:BACKGROUND:Prognostic factors aid in the stratification and treatment of cancer. This study evaluated prognostic importance of tumor infiltrating immune cell in patients with oral squamous cell carcinoma. METHODS:Profiles of infiltrating immune cells and clinicopathological data were available for 78 OSCC patients wit...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3317-2

    authors: Fang J,Li X,Ma D,Liu X,Chen Y,Wang Y,Lui VWY,Xia J,Cheng B,Wang Z

    更新日期:2017-05-26 00:00:00

  • Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala.

    abstract:BACKGROUND:A low cost and accurate method for detecting high-risk (HR) human papillomavirus (HPV) is important to permit HPV testing for cervical cancer prevention. We used a commercially available HPV method (H13, Hybribio) which was documented to function accurately in a reduced volume of cervical specimen to determi...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4438-y

    authors: Lou H,Gharzouzi E,Guerra SP,Fokom Domgue J,Sawitzke J,Villagran G,Garland L,Boland JF,Wagner S,Rosas H,Troxler J,McMillen H,Kessing B,Alvirez E,Castillo M,Morales H,Argueta V,Rosingh A,van Aerde-van Nunen FJHB,Lopez

    更新日期:2018-05-15 00:00:00

  • CC-Chemokine receptor CCR7: a key molecule for lymph node metastasis in esophageal squamous cell carcinoma.

    abstract:BACKGROUND:CC-chemokine receptor 7 (CCR7), a known lymph node homing receptor for immune cells, has been reported as a key molecule in lymph node metastasis. We hypothesized a clinicopathological correlation and functional causality between CCR7 expression and lymph node metastasis in patients with esophageal squamous ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-291

    authors: Irino T,Takeuchi H,Matsuda S,Saikawa Y,Kawakubo H,Wada N,Takahashi T,Nakamura R,Fukuda K,Omori T,Kitagawa Y

    更新日期:2014-04-26 00:00:00

  • VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma.

    abstract:BACKGROUND:Vascular endothelial growth factor (VEGF) isoforms, particularly the diffusible VEGF-121, could play a major role in the response of recurrent glioblastoma (GB) to anti-angiogenetic treatment with bevacizumab. We hypothesized that circulating VEGF-121 may reduce the amount of bevacizumab available to target ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4442-2

    authors: Martini M,de Pascalis I,D'Alessandris QG,Fiorentino V,Pierconti F,Marei HE,Ricci-Vitiani L,Pallini R,Larocca LM

    更新日期:2018-05-10 00:00:00

  • BAG-1 haplo-insufficiency impairs lung tumorigenesis.

    abstract:BACKGROUND:BAG-1 is a multifunctional co-chaperone of heat shock proteins (Hsc70/Hsp70) that is expressed in most cells. It interacts with Bcl-2 and Raf indicating that it might connect protein folding with other signaling pathways. Evidence that BAG-1 expression is frequently altered in human cancers, in particular in...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-4-85

    authors: Götz R,Kramer BW,Camarero G,Rapp UR

    更新日期:2004-11-24 00:00:00

  • Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer.

    abstract:BACKGROUND:The metastasis-promoting protein S100A4 induces expression of ephrin-A1 and osteopontin in osteosarcoma cell lines. The aim of this study was to investigate S100A4-mediated stimulation of ephrin-A1 and osteopontin in non-small cell lung cancer (NSCLC) cell lines, and to characterize the expression of these b...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-333

    authors: Rud AK,Lund-Iversen M,Berge G,Brustugun OT,Solberg SK,Mælandsmo GM,Boye K

    更新日期:2012-08-01 00:00:00

  • Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma.

    abstract:BACKGROUND:The phenomenon that malignant cells can acquire stemness under specific stimuli, encompassed under the concept of cancer cell plasticity, has been well-described in epithelial malignancies. To our knowledge, cancer cell plasticity has not yet been described in hematopoietic cancers. To illustrate and study c...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4300-2

    authors: Wu C,Gupta N,Huang YH,Zhang HF,Alshareef A,Chow A,Lai R

    更新日期:2018-04-02 00:00:00

  • Diagnostic value of retrospective PET-MRI fusion in head-and-neck cancer.

    abstract:BACKGROUND:To assess the diagnostic value of retrospective PET-MRI fusion and to compare the results with side-by-side analysis and single modality use of PET and of MRI alone for locoregional tumour and nodal staging of head-and-neck cancer. METHODS:Thirty-three patients with head-and-neck cancer underwent preoperati...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-846

    authors: Loeffelbein DJ,Souvatzoglou M,Wankerl V,Dinges J,Ritschl LM,Mücke T,Pickhard A,Eiber M,Schwaiger M,Beer AJ

    更新日期:2014-11-19 00:00:00

  • HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC.

    abstract:BACKGROUND:Head and neck squamous cell carcinoma (HNSCC) is the sixth most common tumor in human. Research has shown that HPV status HNSCC is a unique prognosis factor, which may due to its immune infiltration landscape. But the underlying mechanism is unclear. METHODS:In this study, we used a combination of several b...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07298-y

    authors: Zeng H,Song X,Ji J,Chen L,Liao Q,Ma X

    更新日期:2020-08-24 00:00:00

  • Prognostic value of quality of life score in disease-free survivors of surgically-treated lung cancer.

    abstract:BACKGROUND:We aimed to evaluate the prognostic value of quality of life (QOL) for predicting survival among disease-free survivors of surgically-treated lung cancer after the completion of cancer treatment. METHODS:We administered the European Organization for Research and Treatment of Cancer Quality of Life Questionn...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2504-x

    authors: Yun YH,Kim YA,Sim JA,Shin AS,Chang YJ,Lee J,Kim MS,Shim YM,Zo JL

    更新日期:2016-07-20 00:00:00

  • Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.

    abstract:BACKGROUND:Improved insight into the molecular characteristics of the different ovarian cancer subgroups is needed for developing a more individualized and optimized treatment regimen. The aim of this study was to a) identify differentially expressed miRNAs in high-grade serous ovarian carcinoma (HGSC), clear cell ovar...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-80

    authors: Vilming Elgaaen B,Olstad OK,Haug KB,Brusletto B,Sandvik L,Staff AC,Gautvik KM,Davidson B

    更新日期:2014-02-11 00:00:00

  • For patients with breast cancer, geographic and social disparities are independent determinants of access to specialized surgeons. A eleven-year population-based multilevel analysis.

    abstract:BACKGROUND:It has been shown in several studies that survival in cancer patients who were operated on by a high-volume surgeon was better. Why then do all patients not benefit from treatment by these experienced surgeons? The aim of our work was to study the hypothesis that in breast cancer, geographical isolation and ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-351

    authors: Gentil J,Dabakuyo TS,Ouedraogo S,Poillot ML,Dejardin O,Arveux P

    更新日期:2012-08-13 00:00:00

  • miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study.

    abstract:BACKGROUND:Altered expression of microRNAs (miRNAs) is known to contribute to cancer progression. miR-23b and miR-27b, encoded within the same miRNA cluster, are reported to have both tumor suppressive and oncogenic activity across human cancers, including breast cancer. METHODS:To clarify this dichotomous role in bre...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5839-2

    authors: Hannafon BN,Cai A,Calloway CL,Xu YF,Zhang R,Fung KM,Ding WQ

    更新日期:2019-06-28 00:00:00

  • Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survival.

    abstract:BACKGROUND:Kv10.1, a voltage-gated potassium channel only detected in the healthy brain, was found to be aberrantly expressed in extracerebral cancers. Investigations of Kv10.1 in brain metastasis and glioblastoma multiforme (GBM) are lacking. METHODS:We analyzed the expression of Kv10.1 by immunohistochemistry in the...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1848-y

    authors: Martínez R,Stühmer W,Martin S,Schell J,Reichmann A,Rohde V,Pardo L

    更新日期:2015-11-03 00:00:00

  • Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.

    abstract:BACKGROUND:Metronomic chemotherapy is considered an anti-angiogenic therapy that involves chronic administration of low-dose chemotherapy at regular short intervals. We investigated the optimal metronomic dose of oral vinorelbine when given as monotherapy in patients with metastatic cancer. METHODS:Patients with recur...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/1471-2407-13-263

    authors: Briasoulis E,Aravantinos G,Kouvatseas G,Pappas P,Biziota E,Sainis I,Makatsoris T,Varthalitis I,Xanthakis I,Vassias A,Klouvas G,Boukovinas I,Fountzilas G,Syrigos KN,Kalofonos H,Samantas E

    更新日期:2013-05-29 00:00:00

  • Distinct signatures of lung cancer types: aberrant mucin O-glycosylation and compromised immune response.

    abstract:BACKGROUND:Genomic initiatives such as The Cancer Genome Atlas (TCGA) contain data from -omics profiling of thousands of tumor samples, which may be used to decipher cancer signaling, and related alterations. Managing and analyzing data from large-scale projects, such as TCGA, is a demanding task. It is difficult to di...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5965-x

    authors: Lucchetta M,da Piedade I,Mounir M,Vabistsevits M,Terkelsen T,Papaleo E

    更新日期:2019-08-20 00:00:00

  • Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.

    abstract:BACKGROUND:Embryonic Liver Fodrin (ELF) is an adaptor protein of transforming growth factor (TGF-β) signaling cascade. Disruption of ELF results in mislocalization of Smad3 and Smad4, leading to compromised TGF-β signaling. c-Myc is an important oncogenic transcription factor, and the disruption of TGF-β signaling prom...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4379-5

    authors: Ji F,Zhang ZH,Zhang Y,Shen SL,Cao QH,Zhang LJ,Li SQ,Peng BG,Liang LJ,Hua YP

    更新日期:2018-04-24 00:00:00

  • Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer.

    abstract:BACKGROUND:Ovarian cancer is associated with poor long-term survival due to late diagnosis and development of chemoresistance. Tumour hypoxia is associated with many features of tumour aggressiveness including increased cellular proliferation, inhibition of apoptosis, increased invasion and metastasis, and chemoresista...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1539-8

    authors: McEvoy LM,O'Toole SA,Spillane CD,Martin CM,Gallagher MF,Stordal B,Blackshields G,Sheils O,O'Leary JJ

    更新日期:2015-07-25 00:00:00

  • Influence of tumor location on short- and long-term outcomes after laparoscopic surgery for rectal cancer: a propensity score matched cohort study.

    abstract:BACKGROUND:This study aimed to evaluate the short- and long-term outcomes after laparoscopic resection for low rectal cancer (LRC) compared with mid/high rectal cancer (M/HRC). METHODS:Patients with rectal cancer undergoing laparoscopic resection with curative intent were retrospectively reviewed between 2009 and 2015...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07255-9

    authors: Yang H,Yao Z,Cui M,Xing J,Zhang C,Zhang N,Liu M,Xu K,Tan F,Su X

    更新日期:2020-08-14 00:00:00

  • Cancer cell adaptation to chemotherapy.

    abstract:BACKGROUND:Tumor resistance to chemotherapy may be present at the beginning of treatment, develop during treatment, or become apparent on re-treatment of the patient. The mechanisms involved are usually inferred from experiments with cell lines, as studies in tumor-derived cells are difficult. Studies of human tumors s...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-5-78

    authors: Di Nicolantonio F,Mercer SJ,Knight LA,Gabriel FG,Whitehouse PA,Sharma S,Fernando A,Glaysher S,Di Palma S,Johnson P,Somers SS,Toh S,Higgins B,Lamont A,Gulliford T,Hurren J,Yiangou C,Cree IA

    更新日期:2005-07-18 00:00:00

  • Extramammary Paget's disease with the appearance of a nodule: a case report.

    abstract:BACKGROUND:Extramammary Paget's disease (EMPD) remains a rare condition with only a limited number of cases reported in the literature. EMPD is mainly composed of intraepidermal Paget cells, and possesses variable clinical behaviors and histological appearances, leading to difficulty in the diagnosis of this disease. ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-405

    authors: Wang X,Yang W,Yang J

    更新日期:2010-08-04 00:00:00

  • Drug resistance occurred in a newly characterized preclinical model of lung cancer brain metastasis.

    abstract:BACKGROUND:Cancer metastasis and drug resistance have traditionally been studied separately, though these two lethal pathological phenomena almost always occur concurrently. Brain metastasis occurs in a large proportion of lung cancer patients (~ 30%). Once diagnosed, patients have a poor prognosis surviving typically ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06808-2

    authors: Shah N,Liu Z,Tallman RM,Mohammad A,Sprowls SA,Saralkar PA,Vickers SD,Pinti MV,Gao W,Lockman PR

    更新日期:2020-04-07 00:00:00